clinical trial · NCT05089708
AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
Galderma R&D·phase4·completed·n = 123
Acne VulgarisTrifarotene CreamTrifarotene Vehicle Cream
brief summary
The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne vulgaris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks of treatment in facial acne participants
started
Dec 22, 2021
primary completion
Dec 15, 2022
completion
Dec 15, 2022
last updated
Dec 20, 2023
official title
Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol